The Vivos Integrated Practice Program enables you apply the breakthrough science of Pneumopedics®, a practical, life-saving multidisciplinary therapeutic protocol.
The average healthcare provider has over five hundred patients who suffer from a developmental epigenetic condition described in the literature as maxillary hypoplasia and mandibular retrognathia.
Until now the only therapeutic course available to clinicians was surgical intervention or palliative treatments to address the symptoms.
Craniofacial epigenetics is an emerging science with limitless possibilities for resolving many chronic health conditions impacting our world.
At Vivos, we are making significant contributions in this important field.
We make our contributions in six key areas:
The Science of
Pneumopedics® is the physiologic remodeling of the upper airway via naturally-occurring and treatment-induced changes over time.
The Vivos System® incorporates the science of Pneumopedics® in its biomimetic oral appliances and treatment protocols for addressing maxillary hypoplasia and mandibular retrusion.
Pneumpoedics® represents a significant therapeutic application of the principle findings in craniofacial epigenetics.
Vivos provides advanced education to professionals and clinicians across the healthcare spectrum to enable them to apply the science in their healthcare practice.
Our programs are designed to help practitioners obtain the clinical skills to apply the scientific findings in craniofacial epigenetics and Pneumopedics® in their treatment planning and protocols.
Our core business is to provide the scientific understanding and the practical tools to put the science to work in real life.
Maxillary Hypoplasia & Mandibular Retrusion
Maxillary hypoplasia and mandibular retrusion is a condition where the upper and lower jaws are underdeveloped and may result in an obstructed airway.
Some of the warning signs may, but do not necessarily include:
Correcting Maxillary Hypoplasia & Mandibular Retrusion
The clinical goal of treating maxillary hypoplasia and mandibular retrusion is correcting the maxillomandibular skeletal and tissue structures to eliminate or reduce the obstruction of the airway.
Some of the treatment outcomes may include:
In 98% of patients with OSAS, the condition is due to abnormal anatomical features of the soft tissues and/or the structures of the maxillomandibular skeleton that cause a disproportionate anatomy of the airway.*
ARCH OTOLARYNGOL HEAD NECK SURG/VOL 137 (NO. 10), OCT 2011
The Vivos System addresses the abnormal anatomical features of the soft and hard tissues that often contribute to obstructive sleep apnea (OSAS).
Our Scientific Contributions
Millions of people of all ages suffer from a condition described in the medical literature as maxillary hypoplasia and mandibular retrusion.
This all too common condition, where the upper and lower jaws do not fully develop often results in an obstructed or compromised pharyngeal airway.
Individuals who suffer from this condition may develop obstructive sleep apnea or sleep disordered breathing, causing them to periodically stop breathing during sleep.
Vivos is investing in ongoing clinical research and clinical trials to expand it's existing portfolio of therapeutic-grade biomimetic oral appliances for the treatment of maxillary hypoplasia and mandibular retrusion.
The Vivos Therapeutic approach is a safe, non-invasive multidisciplinary protocol for treating maxillary hypoplasia and mandibular retrusion. Successfully correcting the underlying physiologic deficiencies may eliminate the obstruction in the airway.
*Class II Application Pending
Oral Appliance Therapy
Vivos Biomimetic oral appliance therapy is specifically designed to treat maxillary hypoplasia and mandibular retrusion. Vivos Therapeutics is registered with the Federal Drug Administration as a Specification Developer and to date has three medical devices registered:
Three-dimensional model of the airway
of a 59 year old male patient with OSA.
Three-dimensional model of the enhanced airway
of the same patient after 18 months of treatment.
Pneumopedics® is the physiologic remodeling of the upper airway via naturally-occurring and treatment-induced changes over time. Correcting the underlying physiologic deficiencies by correcting maxillary hyposplasia and mandibular retrusion may eliminate the obstruction in the airway.
Pneumopedics® is the physiologic remodeling of the upper airway via naturally-occurring and treatment-induced changes over time. The Vivos System incorporates the science of Pneumopedics® in it's biomimetic oral appliance therapy and treatment protocols for addressing maxillary hypoplasia and mandibular retrusion.
Facial enhancement using biomimetic oral appliance therapy in adults
Dent Oral Craniofac Res
Resolution of Sleep Bruxism using Biomimetic Oral Appliance Therapy: A Case Report
Journal of Sleep Disorders & Therapy
Changes in 3D Midfacial Parameters after Biomimetic Oral Appliance Therapy in Adults
A Novel Combined Protocol for the Resolution of Severe Obstructive Sleep Apnea
Journal of Sleep Disorders & Therapy
A 27-year-old woman was referred to our office for a dental assessment regarding temporomandibular joint pain. On initial screening, she was found to be at high risk for obstructive sleep apnea, and subsequently underwent polysomnography, which revealed an apnea-hypopnea index of 118 hr-1. Her condition was initially controlled with continuous positive airway pressure therapy, which she did not tolerate well.
Therefore, treatment proceeded with biomimetic oral appliance therapy. After 10 months of combined continuous positive airway pressure therapy and biomimetic oral appliance therapy, the apnea-hypopnea index fell to 1 hr-1 and obstructive sleep apnea could not be observed with or without the appliances in situ.
We conclude that combined continuous positive airway pressure therapy and biomimetic oral appliance therapy might represent a potential cure of severe cases obstructive sleep
apnea in certain patients.
ARTICLES AND PUBLICATIONS
The really important
Now that you have a basic understanding of the potentially life-saving possibilities with Pneumopedics®, you must ask yourself, what is my moral obligation to my patients?
You have a professional responsibility to deliver the best standard of care for your patients and the thousands of people in your community who are suffering from obstructive sleep apnea and related breathing disorders. You will never be able to unlearn what the clinical possibilities are.
© 2019 Vivos Therapeutics, Inc. ALL RIGHTS RESERVED
THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS ONLY. All content found on the this website, including text, images, audio, or other formats were created for informational purposes only. The content of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Individual results may vary. Nothing contained in this website infers or creates a warranty, promise, or guarantee of any kind with respect to the clinical outcome or result from treatment using the Vivos technology. The use of the Vivos technologies by any patient must always occur under the direction and supervision of a qualified, trained, and licensed dentist, physician or other qualified health provider, working in close collaboration with qualified medical personnel.